LLY

986.45

+0.17%↑

JNJ

242.9

+0.54%↑

ABBV

221.34

+0.76%↑

NVS

154.3

+0.79%↑

AZN

191.97

+0.98%↑

LLY

986.45

+0.17%↑

JNJ

242.9

+0.54%↑

ABBV

221.34

+0.76%↑

NVS

154.3

+0.79%↑

AZN

191.97

+0.98%↑

LLY

986.45

+0.17%↑

JNJ

242.9

+0.54%↑

ABBV

221.34

+0.76%↑

NVS

154.3

+0.79%↑

AZN

191.97

+0.98%↑

LLY

986.45

+0.17%↑

JNJ

242.9

+0.54%↑

ABBV

221.34

+0.76%↑

NVS

154.3

+0.79%↑

AZN

191.97

+0.98%↑

LLY

986.45

+0.17%↑

JNJ

242.9

+0.54%↑

ABBV

221.34

+0.76%↑

NVS

154.3

+0.79%↑

AZN

191.97

+0.98%↑

Home・Aandelen Lijst・Avita Therapeutics Inc

Avita Therapeutics Inc

Gesloten

4.61 4.77

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

4.4

Max

4.74

Belangrijke statistieken
By Trading Economics
Inkomsten	1.6M -12M
Verkoop	554K 18M
EPS	-0.536
Winstmarge	-65.968
Werknemers	226
EBITDA	1.6M -9.7M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+43.86% upside

Dividenden
By Dow Jones
Volgende Winsten	7 mei 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	28M 152M
Vorige openingsprijs	-0.16
Vorige sluitingsprijs	4.61

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

8.83 / 9.77 Steun & Weerstand

Avita Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

15 mrt 2026, 21:14 UTC

Belangrijke Nieuwsgebeurtenissen

Week Ahead for FX, Bonds: Central Bank Decisions -2-

15 mrt 2026, 21:14 UTC

Belangrijke Nieuwsgebeurtenissen

Week Ahead for FX, Bonds: Central Bank Decisions in Focus After Jump in Energy Prices

16 mrt 2026, 00:00 UTC

Belangrijke Nieuwsgebeurtenissen

Hack on U.S. Medical Company Shows Reach of Iran's Cyber Capabilities -- WSJ

15 mrt 2026, 23:45 UTC

Marktinformatie

Nikkei May Decline on Concerns About Prolonged Middle East Conflict -- Market Talk

15 mrt 2026, 23:44 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Gold Falls as Rising Energy Prices Exacerbate Inflation Worries -- Market Talk

15 mrt 2026, 23:35 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Oil Futures Rise on Supply Disruption Concerns -- Market Talk

15 mrt 2026, 23:00 UTC

Acquisities, Fusies, Overnames

Micron Completes Acquisition Of PSMC's Tongluo P5 Site In Taiwan >MU

15 mrt 2026, 22:37 UTC

Marktinformatie

March Rate Hike Would Distance RBA From Government's May Budget -- Market Talk

15 mrt 2026, 22:18 UTC

Marktinformatie

RBA's Likely Hike Motivated By Inflation, Not Middle East -- Market Talk

15 mrt 2026, 22:14 UTC

Winsten

Genscript Biotech 2025 Adj Net $230.35M Vs. Adj Net $59.83M>1548.HK

15 mrt 2026, 22:14 UTC

Winsten

Genscript Biotech: 2025 Loss Due to High Base Effect, One-off Unrealized Gains Seen Last Year >1548.HK

15 mrt 2026, 22:14 UTC

Winsten

Genscript Biotech 2025 Rev $959.53M Vs. $594.49M >1548.HK

15 mrt 2026, 22:14 UTC

Winsten

Genscript Biotech 2025 Loss $532.83M Vs. Net $2.96B >1548.HK

15 mrt 2026, 22:14 UTC

Winsten

Genscript Biotech: 2025 Rev Supported by Substantial Increase in License Revenue>1548.HK

15 mrt 2026, 22:00 UTC

Belangrijke Nieuwsgebeurtenissen

Oil Industry Warns Trump Administration Energy Crisis Will Likely Worsen -- WSJ

15 mrt 2026, 22:00 UTC

Belangrijke Nieuwsgebeurtenissen

Oil Industry Warns Trump Administration Energy Crisis Will Likely Worsen -- WSJ

15 mrt 2026, 03:00 UTC

Belangrijke Nieuwsgebeurtenissen

For Xi, Iran War Reinforces View of U.S. as Dangerous Superpower -- WSJ

14 mrt 2026, 15:00 UTC

Belangrijke Nieuwsgebeurtenissen

Iran War Delivers Windfall to America's Oil Country -- WSJ

14 mrt 2026, 02:03 UTC

Winsten

This Copper Stock Is Worth Mining for Profits -- Barrons.com

14 mrt 2026, 01:32 UTC

Acquisities, Fusies, Overnames

Bill Ackman's Pershing Square IPO Is Back On -- Barrons.com

14 mrt 2026, 00:29 UTC

Acquisities, Fusies, Overnames

13D Filings -- Barrons.com

13 mrt 2026, 22:27 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Bahrain Faces Uncertainty But Has Support Amid War, S&P Says -- Market Talk

13 mrt 2026, 22:13 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Saudi Arabia Seen as Able to Weather Iran Conflict, S&P Says -- Market Talk

13 mrt 2026, 22:04 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Emirate of RAK Outlook Stable Despite Iran War, S&P Says -- Market Talk

13 mrt 2026, 22:00 UTC

Acquisities, Fusies, Overnames

Trump Administration Set to Receive $10 Billion Fee for Brokering TikTok Deal -- WSJ

13 mrt 2026, 20:50 UTC

Marktinformatie

Health Care Roundup: Market Talk

13 mrt 2026, 20:50 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Financial Services Roundup: Market Talk

13 mrt 2026, 20:02 UTC

Marktinformatie

Canada Rate Hike in 2026 Would Mark 'Extraordinarily Bad' Policy -- Market Talk

13 mrt 2026, 19:50 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Oil Posts Weekly Gains As Middle East Conflict Drags On -- Market Talk

13 mrt 2026, 19:35 UTC

Belangrijke Nieuwsgebeurtenissen

Oil Prices Hover Near $100. India Asks Iran to Allow 23 Tankers Through Strait of Hormuz. -- Barrons.com

Peer Vergelijking

Prijswijziging

Avita Therapeutics Inc Prognose

Koersdoel

By TipRanks

43.86% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 6.33 USD 43.86%

Hoogste 10 USD

Laagste 3.5 USD

Gebaseerd op 4 Wall Street-analisten die 12-maands prijsdoelen bieden voor Avita Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

4 ratings

Buy

Hold

Sell

Gebaseerd op 4 analisten die aandelenratings hebben gegeven aan Avita Therapeutics Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

8.83 / 9.77Steun & Weerstand

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.